Exploring how our genes affect health and disease through advanced DNA analysis.
HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE - WHOLE GENOME SEQUENCING, 30X COVERAGE FOR NEI (SHEN)
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-11219956
This study is looking at how your genes might affect your health by analyzing DNA samples, and if you join, you could help us learn more about the connection between genetics and different health conditions.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11219956 on ClinicalTrials.gov |
What this research studies
This research focuses on using high throughput genotyping and whole genome sequencing to investigate the genetic factors that contribute to human health and disease. By analyzing DNA samples with 30X coverage, the study aims to uncover genetic variations that may influence various health conditions. Patients may have the opportunity to contribute their genetic information, which could lead to a better understanding of how genetics play a role in their health. The methodology involves collecting DNA samples and performing detailed genetic analyses to identify potential links between genes and health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in understanding the genetic factors that may affect their health and are willing to provide DNA samples.
Not a fit: Patients with no interest in genetic research or those who do not wish to provide DNA samples may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized medical approaches based on genetic insights, improving health outcomes for patients.
How similar studies have performed: Previous research using high throughput genotyping and whole genome sequencing has shown promise in identifying genetic contributions to various health conditions, indicating a strong potential for success in this approach.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.